Altris AI, which offers OCT analysis for retinal diseases, is now expanding to glaucoma detection.With its optic disc ...
Nikhil Lalwani, President and CEO of ANI stated, "ILUVIEN's expanded label and the strengthening of our partnership with long ...
ANI Pharmaceuticals, Inc.: ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN Label
ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to diabetic macular edema (DME)ANI plans to begin marketing ILU ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results